The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public that the Singapore Health Science Authority (HSA) has issued a recall of all unexpired lots of Nitroglycerin injection manufactured by Advanced Pharma, Inc. doing business as Avella of Houston, USA.
The recall issued on June 29, 2017, was due to a laboratory test result which indicated a lower than expected potency on certain lots of compounded Nitroglycerin injection which may lead to a lower dose being administered. The result, serious health complications.
Nitroglycerine is used to control high blood pressure, congestive heart failure, lung congestion and chest pain especially in heart attack patients. It decreases the workload on the heart by enlarging (dilating) blood vessels
Product Name: Nitoglycerin Injection
Lot Number: All unexpired lots
Manufacturing Dates: March 3, and May 31, 2017
Manufacturer: Advanced Pharma, Inc. doing business as Avella of Houston USA.
Healthcare Provider Action